中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2013年
3期
282-285
,共4页
袁海成%许波%陈晶%王岭%孙丽
袁海成%許波%陳晶%王嶺%孫麗
원해성%허파%진정%왕령%손려
颈动脉疾病%颈动脉支架置入术%Mo.Ma脑保护装置
頸動脈疾病%頸動脈支架置入術%Mo.Ma腦保護裝置
경동맥질병%경동맥지가치입술%Mo.Ma뇌보호장치
Carotid artery disease%Carotid artery stenting%Mo.Ma cerebral protection device
目的 探讨颈动脉狭窄支架置入术(CAS)中使用Mo.Ma脑保护装置的价值. 方法 回顾性分析青岛市中心医院神经内科自2009年3月至2011年9月收治的8例行CAS并使用Mo.Ma脑保护装置的颈内动脉重度狭窄患者的临床资料. 结果 Mo.Ma脑保护装置保护成功率及CAS手术成功率均为100%,颈内动脉重度狭窄均有改善,残余狭窄率均低于30%;1例回抽血液中见捕获的小斑块,无患者发生栓子脱落事件;术后复查头部MRI,未发现新发的缺血病灶;术后1个月复查颈部血管彩超均未发现再狭窄. 结论 对颈内动脉重度狭窄的患者行CAS时,使用Mo.Ma脑保护装置安全、有效,但仍需大样本病例进一步证实.
目的 探討頸動脈狹窄支架置入術(CAS)中使用Mo.Ma腦保護裝置的價值. 方法 迴顧性分析青島市中心醫院神經內科自2009年3月至2011年9月收治的8例行CAS併使用Mo.Ma腦保護裝置的頸內動脈重度狹窄患者的臨床資料. 結果 Mo.Ma腦保護裝置保護成功率及CAS手術成功率均為100%,頸內動脈重度狹窄均有改善,殘餘狹窄率均低于30%;1例迴抽血液中見捕穫的小斑塊,無患者髮生栓子脫落事件;術後複查頭部MRI,未髮現新髮的缺血病竈;術後1箇月複查頸部血管綵超均未髮現再狹窄. 結論 對頸內動脈重度狹窄的患者行CAS時,使用Mo.Ma腦保護裝置安全、有效,但仍需大樣本病例進一步證實.
목적 탐토경동맥협착지가치입술(CAS)중사용Mo.Ma뇌보호장치적개치. 방법 회고성분석청도시중심의원신경내과자2009년3월지2011년9월수치적8례행CAS병사용Mo.Ma뇌보호장치적경내동맥중도협착환자적림상자료. 결과 Mo.Ma뇌보호장치보호성공솔급CAS수술성공솔균위100%,경내동맥중도협착균유개선,잔여협착솔균저우30%;1례회추혈액중견포획적소반괴,무환자발생전자탈락사건;술후복사두부MRI,미발현신발적결혈병조;술후1개월복사경부혈관채초균미발현재협착. 결론 대경내동맥중도협착적환자행CAS시,사용Mo.Ma뇌보호장치안전、유효,단잉수대양본병례진일보증실.
Objective To investigate the safety and effectiveness of Mo.Ma proximal cerebral protection device during carotid artery stenting (CAS).Methods Eight patients with high-grade carotid artery stenosis,admitted to and underwent carotid artery stenting using Mo.Ma cerebral protection device in our hospital from March 2009 to September 2011,were chosen in our study; their clinical data were retrospectively analyzed.Results The device success rate and procedural success rate were 100%,and the residual stenosis was less than 30%.The debris was captured in the aspirated blood in one patient.No patient had deficit caused by emboli.No new ischemic lesions were found in post-operative MRI-diffused weighted imaging,and no restenosis was noted under neck vascular ultrasound one month after the operation.Conclusion The Mo.Ma proximal cerebral protection device is safe and effective for patients with high-grade internal carotid stenosis undergoing carotid artery stenting,but the prospective multicenter registry trials need to date.